Table of Contents Table of Contents
Previous Page  396 / 812 Next Page
Information
Show Menu
Previous Page 396 / 812 Next Page
Page Background

S392

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S349–S805

to collecting demographic data including self-report about discon-

tinuation of the treatment in past.

Results

We examined data from 99 patients (54 males) suffering

from severe mental disorders and 86 patients (41 males) suffer-

ing from anxiety spectrum disorders. There were no statistically

significant differences between these two groups in gender, age,

education or marital status. In both groups, we proved signifi-

cant correlation between level of self-stigmatization and adherence

to treatment (

r

=

0.320, respectively

r

=

0.432). Up to our

results, there were no statistically significant differences between

both groups in level of self-stigmatization (

P

= 0.656), adher-

ence to treatment (

P

= 0.474) and discontinuation of medication

(

P

= 0.231).

Conclusions

Level of self-stigmatization proved to be an

important factor in influencing both level of adherence and

discontinuation of drugs in both subgroups of patients. There

were no differences between self-stigmatization or adherence

between subgroups. More attention should be paid to issue of

self-stigmatization throughout whole diagnostic spectrum of psy-

chiatric patients.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.1115

EV131

Gender differences in anxiety among

secondary school in Kuwait

S. Kareemi

Kuwait University, Faculty of Social Sciences, Psychology, Kaifan,

Kuwait

Introduction

Anxiety disorders are themost commonmental dis-

orders, and their prevalence is substantially higher in women than

inmen. Research has confirmed the existence of gender differences

in several types of anxiety disorders.

Objectives

The current investigation sought to determine

whether any observable gender differences existed in anxiety for a

nonclinical sample.

Methods

the sample consisted of 300 males and 300 female

students from a secondary school in Kuwait. The genders were

matched in age (males = 16.52

±

0.90 & females = 16.37

±

0.96,

t

= 1.93,

P

> .05). The inclusion criteria for all participants: sample

of the population of Al-Jahra city, aged between 15 and 18 years

old, school grades 10, 11, 12, and the social status of the parents

(married). The Arabic version of Beck Anxiety Inventory (BAI) was

administered to participants. BAI reliabilities ranged from .88 to

.87 with a mean .87 (alpha) denoting good internal consistency.

The convergent correlations in eight samples between BAI and

Kuwait University Anxiety Scale KUAS (mean

r

= .52) for validity

coefficients.

Results

The results revealed that females (18.67

±

11.11) had sig-

nificantly higher mean anxiety than their male (14.52

±

10.37)

counterparts (

f

= 22.27,

P

< .000).

Conclusion

Therefore, we can conclude that female preponder-

ance of anxiety has been a consistent finding within literature.

Disclosure of interest

The author has not supplied his declaration

of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.1116

EV132

A research on anxiety disorder

prevalence and severity among

vestibuler migraine and migraine

patients

Ö. Kutay Yüksel

1 ,

, G. Akdal

2

, T. Alkın

3

, B. Dönmez Balcı

1

1

Dokuz Eylul University, Clinical Neuroscience, Izmir, Turkey

2

Dokuz Eylul University, Neurology, Izmir, Turkey

3

Dokuz Eylul University, Psychiatry, Izmir, Turkey

Corresponding author.

In this research, anxiety, depression symptoms and severity were

compared between healthy controls (HC), vestibulermigraine (VM)

and migraine patients without history of vertigo (MO).

Method

Thirty-five definite vestibulermigraine patients (accord-

ing to Neuhauser criteria), 35 MO patients and 32 healthy

controls were included. All patients were evaluated for their life-

time psychiatric disorders with Structured Clinical Interview for

DSM–IV/Clinical version (SCID-I/CV). All three groups evaluated by:

– Hamilton Anxiety Rating Scale (HARS);

– State-Trait Anxiety Inventory (STAI), (STAI-X1) and the other trait

anxiety STAI-X2);

– Beck depression inventory (BDI);

– Lifetime Panic Agoraphobic Spectrum Scale (PAS-SR);

– Penn State Worry Questionnaire (PENN);

– Separation Anxiety Symptoms Inventory (SASI);

– Adult Separation Anxiety Questionnaire (ASA).

Psychiatric diagnosis history (SCID-I); comparison of VM and MO

did not indicate a significant difference (

P

< 0.05). VM and MO

patients were significantly different than HC in terms of anxiety

symptoms in “HAM-A, PENN, ASA, PAS-SR and PAS-SR subscales

(

P

< 0.05)”. VM was significantly different than MO patients in

BDE and PAS-SR (overall; separation anxiety, agoraphobia, reas-

surance seeking) (

P

< 0.05). The longer the history of migraine the

higher was the anxiety points in both in VM and MO patients

(

P

< 0.05). Headache and vertigo severity inVMpatientswere signif-

icantly correlated with the elevated anxiety and depression points

(

P

< 0.05).

Conclusion

VM and MO patients significantly different in anxi-

ety and mood disorder when compared with healthy controls. Our

findings showed that VM patients were more vulnerable to psychi-

atric disorders. For that reason, multidisciplinary approach for the

treatment of VM may facilitate the treatment process.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2016.01.1117

EV133

The Balkan region preferences for the

treatment of anxiety disorders

M. Latas

1 ,

, D. Bonevski

2

, A. Andromahi Naumovska

2

1

Belgrade, Serbia

2

П

c

и

х

и

j

ɑ

t

ри

c

к

ɑ

б

ол

h

иц

ɑ

C

к

о

п

j

e

”,

Ц

e

ht

ɑ

р

з

ɑ

м

e

ht

ɑ

л

h

о

з

др

ɑ

в

j

e

Ц

e

ht

ɑ

р

”, Skopje, The Former Yugoslav Republic of Macedonia

Corresponding author.

Themost countries fromWest Balkan region do not have the official

guidelines for the treatment of patientswith anxiety disorders (AD).

We have done the survey on preferences of treatment of patients

with AD. We have collected data from sample of 221 psychiatrists

from Croatia (41 psychiatrists), Macedonia (81 psychiatrists) and

Serbia (99 psychiatrists). They give as information about their pref-

erences for treating patients with AD.

The results indicate that the vast majority of psychiatrists report

that almost all patients with AD receive benzodiazepines prior

to first psychiatric visit. The majority of psychiatrist would opt

for SSRI/SNRI antidepressants (91–97%) as the monotherapy or in

combination with benzodiazepines (53–59%) or in combination

with cognitive-behavior (25–35%) or psychodynamic psychother-

apy (12–16%).

The most indicative difference between psychiatrists from differ-

ent countries is result about the use of pregabalin – almost half of

Serbian subsample would opt for pregabalin, but only a quarter of

Croatian subsample and no psychiatrist fromMacedonian subsam-

ple would choose pregabalin. Also, much more Macedonian and

Serbian psychiatrist would opt for CBT treatment, but, in contrast,

much more Croatian psychiatrist would opt for psychodynamic